RFP Transduced (human) Cord Blood Endothelial Progenitor Cells (RFP-CB-EPC) are an extension of our high-quality EPCs but with the added benefit of Red Fluorescent Protein.

Transduction was accomplished using custom packaged lentivirus.

CELLvo™ RFP-transduced cord blood endothelial progenitor cells (RFP-CB-EPCs) have several promising applications in research and therapy:

Vascular Regeneration: These cells can be used to repair and regenerate damaged blood vessels, which is crucial in treating cardiovascular diseases.

Tissue Engineering: They play a significant role in developing engineered tissues and organs by providing the necessary vascular networks.

Cancer Research: RFP-CB-EPCs are used to study tumor angiogenesis, the process by which tumors develop their own blood supply, which is essential for cancer growth and metastasis.

Drug Testing: These cells provide a model to test the efficacy and safety of new drugs targeting vascular diseases.

Gene Therapy: They can be genetically modified to deliver therapeutic genes to specific tissues, offering potential treatments for various genetic disorders.

CELLvo™ Cells are for Research Use Only.